|
|
|
|
LEADER |
03952nam a2200721 4500 |
001 |
ocn858861712 |
003 |
OCoLC |
005 |
20170124071242.9 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130924s2013 nju ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d E7B
|d CUS
|d WAU
|d CDX
|d COO
|d NLGGC
|d YDXCP
|d EBLCP
|d K6U
|d OCLCF
|d DEBBG
|d GrThAP
|
019 |
|
|
|a 862828741
|a 961559519
|a 962711076
|
020 |
|
|
|a 9781118660379 (ePDF)
|
020 |
|
|
|a 1118660374 (ePDF)
|
020 |
|
|
|z 9781118179796
|
020 |
|
|
|z 111817979X
|
020 |
|
|
|a 9781118659984 (epub)
|
020 |
|
|
|a 1118659988 (epub)
|
020 |
|
|
|a 9781118660409 (emobi)
|
020 |
|
|
|a 1118660404 (emobi)
|
020 |
|
|
|a 9781118660485
|
020 |
|
|
|a 111866048X
|
029 |
1 |
|
|a AU@
|b 000052334807
|
029 |
1 |
|
|a NZ1
|b 15340181
|
029 |
1 |
|
|a DEBBG
|b BV041572424
|
029 |
1 |
|
|a NLGGC
|b 369354931
|
029 |
1 |
|
|a AU@
|b 000052749422
|
029 |
1 |
|
|a DEBBG
|b BV043396228
|
035 |
|
|
|a (OCoLC)858861712
|z (OCoLC)862828741
|z (OCoLC)961559519
|z (OCoLC)962711076
|
050 |
|
4 |
|a RS380
|
060 |
1 |
4 |
|a QV 35
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.19
|2 23
|
049 |
|
|
|a MAIN
|
100 |
1 |
|
|a Ho, Rodney J. Y.
|
245 |
1 |
0 |
|a Biotechnology and biopharmaceuticals :
|b transforming proteins and genes into drugs /
|c Rodney J.Y. Ho and Milo Gibaldi.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a Hoboken, New Jersey :
|b Wiley Blackwell,
|c [2013]
|
264 |
|
4 |
|c ©2013
|
300 |
|
|
|a 1 online resource (xxvi, 698 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Introduction to biopharmaceuticals -- Distinctions of biologic versus small molecule platforms in drug development -- Financing biologic drug development -- Application of biotechnology in drug discovery and early development -- Large-scale production of recombinant proteins -- Clinical pharmacology, toxicology, and therapeutic dosage & response -- Clinical evaluation and regulatory approval & enforcement of biopharmaceuticals -- Pharmacoeconomics and drug pricing / Garrison -- Antibodies and derivatives -- Hematopoietic growth and coagulation factors -- Cytokines and interferons -- Hormones -- Enzymes -- Vaccines / Hu, Ho -- Other biopharmaceutical products -- Advances in personalized medicine : pharmacogenetics in drug therapy -- Gene and cell therapy -- Pharmacoeconomics, outcome, and health technology assessment research in drug development -- Summary and future prospects.
|
588 |
|
|
|a Description based on print version record.
|
520 |
|
|
|a Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs, Second Edition addresses the pivotal issues relating to translational science, including preclinical and clinical drug development, regulatory science, pharmaco-economics and cost-effectiveness considerations. The new edition also provides an update on new proteins and genetic medicines, the translational and integrated sciences that continue to fuel the innovations in medicine, as well as the new areas of therapeutic development including cancer vaccines, stem cell therapeutics, and cell-based therapies.
|
650 |
|
0 |
|a Pharmaceutical biotechnology.
|
650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
650 |
|
2 |
|a Biopharmaceutics.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical.
|
650 |
|
2 |
|a Drug Design.
|
650 |
|
4 |
|a Biopharmaceutics.
|
650 |
|
4 |
|a Chemistry, Pharmaceutical.
|
650 |
|
4 |
|a Drug design.
|
650 |
|
7 |
|a Pharmaceutical biotechnology.
|2 fast
|0 (OCoLC)fst01060106
|
655 |
|
4 |
|a Electronic books.
|
655 |
|
0 |
|a Electronic books.
|
700 |
1 |
|
|a Gibaldi, Milo.
|
776 |
0 |
8 |
|i Print version:
|a Ho, Rodney J. Y.
|t Biotechnology and biopharmaceuticals.
|b Second edition
|z 9781118179796
|w (DLC) 2013006645
|w (OCoLC)828334052
|
856 |
4 |
0 |
|u https://doi.org/10.1002/9781118660485
|z Full Text via HEAL-Link
|
994 |
|
|
|a 92
|b DG1
|